CV Sciences Inc. (OTCMKTS: CVSI) has launched four distinctive over-the-counter +PlusCBD Pain Relief topicals that have been formulated to target sources of minor aches and pains...
CV Sciences Inc. (OTCMKTS: CVSI) has announced its third-quarter 2021 financial results for the period ending September 30, 2021. Revenue dropped to $5.1 million. In Q3...
CV Sciences Inc (OTCMKTS: CVSI) has been performing remarkably as a company focusing on hemp-derived cannabidiol (CBD) products, and today it highlights its plans for the future....
The CBD industry has been one of the hardest hit market segments over the past 18 months. But the long-term structural growth trend continues to look...
CV Sciences Inc (OTCMKTS:CVSI) provides an excellent case study in understanding market forces at work. The company is arguably one of the most impressive growth stories...
CV Sciences Inc (OTCMKTS:CVSI) is possibly beginning to show some renewed signs of life following a period of heavy doubt that was initially sparked by a...
Even though it is under fire from law firms and battling poor sentiment, CV Sciences Inc (OTCMKTS:CVSI) shares have started to surge back to the upside...
CV Sciences Inc (OTCMKTS:CVSI) has announced its financial results for the fourth quarter and year ended December 31, 2017. The company reported sales of $7.2 million...
CV Sciences Inc (OTCMKTS:CVSI) announced recently that it has repaid the April 2018 installment obligation on its Convertible Promissory Note in cash to avoid the lender...
CV Sciences Inc (OTCMKTS:CVSI) reported that it will be showcasing its industry-leading brand of hemp-derived Cannabidiol oil finished offerings, PlusHemp Oil™, at this year’s Integrative Health...
